Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey
Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 2, pp. 384-390.e1
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
Mohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 10, pp. 864-873
Closed Access | Times Cited: 208
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
Terry Cheuk‐Fung Yip, Eduardo Vilar‐Gómez, Salvatore Petta, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1404-1427
Closed Access | Times Cited: 78
Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017–2018
Xiaotao Zhang, Natalia I. Heredia, Maya Balakrishnan, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252164-e0252164
Open Access | Times Cited: 89
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
Lu Pan, Pan Huang, Xia Xie, et al.
Digestive and Liver Disease (2020) Vol. 53, Iss. 2, pp. 153-157
Open Access | Times Cited: 88
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 2, pp. 150-163
Open Access | Times Cited: 76
Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease
Jingfei Chen, Yingjie Su, Xin Su, et al.
Diabetes Research and Clinical Practice (2023) Vol. 201, pp. 110733-110733
Closed Access | Times Cited: 23
Associations between the platelet/high-density lipoprotein cholesterol ratio and likelihood of nephrolithiasis: a cross-sectional analysis in United States adults
Junjie Ni, Lin Lv, Pu Wu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 15
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis
Stefano Ciardullo, Guıdo Grassı, Giuseppe Mancia, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 4, pp. 365-371
Open Access | Times Cited: 53
Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017–2018
Eduardo Vilar‐Gómez, Raj Vuppalanchi, Andrea Mladenovic, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 21, Iss. 1, pp. 115-124.e7
Open Access | Times Cited: 44
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
Stefano Ciardullo, Gianluca Perseghin
Diabetes Research and Clinical Practice (2022) Vol. 190, pp. 109981-109981
Closed Access | Times Cited: 35
Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea
Mimi Kim, Eileen L. Yoon, Seon Cho, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1536-1544
Closed Access | Times Cited: 29
Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018
Julia Y. Payne, Naim Alkhouri, Phuc Le, et al.
Hepatology Communications (2023) Vol. 7, Iss. 1, pp. e0019-e0019
Open Access | Times Cited: 18
Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome
T. H. Kuo, Yang‐Bor Lu, Chiehlun Yang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies
Yan-Lin Liao, Gen-Yuan Zhu, Cheng Chang
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 6
Examining the cross-sectional relationship of platelet/high-density lipoprotein cholesterol ratio with depressive symptoms in adults in the United States
Junjie Ni, Pu Wu, L. Xiaofeng, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population
Stefano Ciardullo, Emanuele Muraca, Francesca Zerbini, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 8, pp. e2856-e2865
Open Access | Times Cited: 36
Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study
Zhiyuan Weng, Weijie Ou, Jiaofeng Huang, et al.
Nature and Science of Sleep (2021) Vol. Volume 13, pp. 103-111
Open Access | Times Cited: 33
The association between non‐alcoholic fatty liver disease and serum ferritin levels in American adults
Naibin Yang, Yi Lu, Cao Liwen, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 2
Open Access | Times Cited: 25
Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis
Stefano Ciardullo, Emanuele Muraca, Rosa Cannistraci, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 5
Open Access | Times Cited: 16
Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018
Zheng Yang, Daoqing Gong, Xinxiang He, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population
Stefano Ciardullo, Tommaso Monti, Guıdo Grassı, et al.
Journal of Hypertension (2021) Vol. 39, Iss. 8, pp. 1621-1627
Open Access | Times Cited: 32
Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease
Sander Lefere, Ellen Dupont, Ann De Guchtenaere, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 10, pp. 2317-2326.e4
Open Access | Times Cited: 31
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis.
Stefano Ciardullo, Guıdo Grassı, Giuseppe Mancia, et al.
PubMed Central (2022) Vol. 34, Iss. 4, pp. 365-371
Open Access | Times Cited: 22
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
Stefano Ciardullo, Marco Carbone, Pietro Luigi Invernizzi, et al.
Hepatology Communications (2022) Vol. 6, Iss. 8, pp. 2070-2078
Open Access | Times Cited: 21
The Association of Metabolic-associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis
Umar Hayat, Muhammad Ashfaq, Luke Johnson, et al.
Kansas Journal of Medicine (2022) Vol. 15, Iss. 2, pp. 241-246
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top